Нові антимікробні агенти з ряду заміщених ариламідів 4-(4- оксо -4H-хіназолін-3-іл)-піперидин-1-карбонових кислот

The methods for the synthesis of the substituted arylamides of 4-(4-oxo-4H-quinazolin-3-yl)-piperidine-1-carboxylic acids using the technologies of the liquid-phase parallel synthesis have been developed. The structure of the compounds obtained has been confi rmed by the data of the instrumental meth...

Повний опис

Збережено в:
Бібліографічні деталі
Дата:2016
Автори: Krolenko, K. Yu., Vlasov, S. V., Zhuravel, I. O., Osolodchenko, T. P.
Формат: Стаття
Мова:English
Опубліковано: National University of Pharmacy 2016
Теми:
Онлайн доступ:https://ophcj.nuph.edu.ua/article/view/ophcj.16.877
Теги: Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
Назва журналу:Journal of Organic and Pharmaceutical Chemistry

Репозитарії

Journal of Organic and Pharmaceutical Chemistry
Опис
Резюме:The methods for the synthesis of the substituted arylamides of 4-(4-oxo-4H-quinazolin-3-yl)-piperidine-1-carboxylic acids using the technologies of the liquid-phase parallel synthesis have been developed. The structure of the compounds obtained has been confi rmed by the data of the instrumental methods of organic analysis. The antibacterial activity of the compounds obtained has been studied using the agar “well” diffusion method against the standard test-strains of microorganisms. The results of the screening performed have shown that all compounds inhibit the growth of Staphylococcus aureus and Bacillus subtilis strains. The strains of Proteus vulgaris and Pseudomonas aeruginosa have been found to be the most resistant. The SAR-analysis of the substituted arylamides of 4-(4-oxo-4H-quinazolin-3-yl)-piperidine-1-carboxylic acids has demonstrated that the presence of the electron-donating substituents in position 8 of the quinazolin-4-one cycle and in position 4 of the aromatic fragment of the urea increases the activity of the compounds of this series against gram-positive bacteria. Such high effi cacy of the lead compounds against the gram-positive bacterial strains can be applied for creating the narrow spectrum antibiotics derived from arylamides of 4-(4-oxo-4H-quinazolin-3-yl)-piperidine-1-carboxylic acids.